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Abstract Traditional medicinal practices have a profound influence on the daily lives of people living in developing
countries, particularly in Africa, since the populations cannot generally afford the cost of Western medicines. We have
undertaken to investigate the correlation between the uses of plants in Traditional African medicine and the biological
activities of the derived natural products, with the aim to validate the use of traditional medicine in Northern African
communities. The literature is covered for the period 1959–2015 and part III of this review series focuses on plant families
with names beginning with letters T to Z. The authors have focused on curating data from journals in natural products and
phytomedicine. Within each journal home page, a query search based on country name was conducted. All articles ‘‘hits’’
were then verified, one at a time, that the species was harvested within the Northern African geographical regions. The
current data partly constitutes the bases for the development of the Northern African natural compounds database. The
review discusses 284 plant-based natural compounds from 34 species and 11 families. It was observed that the ethnob-
otanical uses of less than 40 % of the plant species surveyed correlated with the bioactivities of compounds identified.
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1 Introduction
Northern Africa includes the countries Algeria, Egypt,
Libya, Morocco, North Sudan, South Sudan, Tunisia and
Western Sahara, covering a land surface of about
8935659 km2 [1]. This region is mostly covered by the
Sahara desert (a surface area of[50 % of the total area of
the region), the rest of the region being oases and grass-
lands, with a total of 343 vascular plant species from 69
families non-native to this region [2]. The use of these
plants for the treatment of disease ailments is known and
documented from the Ancient Egyptian civilization [3].
Till today, diverse plant parts (roots, rhizomes, flowers,
leaves, fruits, seeds and oils; in the form of powders, pills,
suppositories, creams, pastes, and ointments, or sometimes
combinations of these) are often used locally in traditional
medicine within this region and the herbal material is
commonly commercialized in the local markets. Urban-
ization and desertification however represent constant
threats to some of the plant species [4–6]. Although Arabic
traditional medicine is in danger of disappearing as a result
of the influence of Western medicine [7], the use of plant-
based medicines in Africa, as a whole, dates back to several
centuries and several attempts have been made by gov-
ernment authorities to ensure its continuity [8]. Addition-
ally, scientists have attempted to record and study the old
recipes with the view of identifying the active principles in
the herbal preparations and understanding the modes of
action of the bioactive principles, with the ultimate goal of
developing phytomedicines and/or drugs from these
preparations [6]. It should be noted that traditional medi-
cine is not just commonly practised in Northern Africa, but
in the entire continent, to the extent that traditional medi-
cine has been included as one of the hubs of the African
Network for Drugs and Diagnostics Innovation (ANDI) [9–
11].
The assertion that natural products represent a huge
potential for drugs and drug leads cannot be disputed [12].
This is because nature uses exquisite enzyme reaction
sequences, conducts many chemical transformations with
high regio- and stereospecificity, leading to the formation
of secondary metabolites [13]. These secondary metabo-
lites (originally designed by plants for their own defence
mechanism and survival) could be used directly as drugs or
further chemically modified to give drug molecules. A
quick search of the literature (the main stream natural
products journals and PhD theses from university libraries
in Northern Africa) could give an estimate of [3000
unique compounds which have been previously isolated
from Northern African flora, algae and fauna. Although the
database of natural compounds from Northern African
sources is still under construction, a recent survey has been
undertaken by two of us to investigate the correlation that
exists between the biological activities of the isolated
metabolites from Northern African floral matter and the use
of the respective plant species in local traditional medicine
[14, 15]. The current review paper represents a continua-
tion of this survey, with plants belonging to families having
names beginning with letters T to Z (34 species and 11
families). As in the two previous reviews, the plant families
have been presented in alphabetical order. Wherever the
biological activities of the isolated metabolites correlate
with the ethnobotanical uses of the plant species, these are
highlighted in bold in the Tables.
2 Taccaceae and Tamaricaceae
Taccaceae or Dioscoreales (the family of yams), particu-
larly the genus Tacca, is mostly characterised by the
presence of taccalonolides (a new class of plant-derived
natural steroids with a microtubule-stabilizing activity,
withanolides and their glucosides, saponins, pregnane
glycosides, diarylheptanoids and their glycosides, the iso-
lated compounds mostly showing cytotoxic, microtubule-
stabilizing, NF-jB activation, PPAR transcriptional and
insecticidal activities [16]. A summary of the medicinal
uses and biological activities of the compounds of the
Taccaceae and Tamaricaceae from Northern Africa are
shown in Table 1. The plant species Tacca leon-
topetaloides (Taccaceae or Dioscoreaceae, the yam family)
is native to tropical Africa, South Asia, Southeast Asia,
Northern Australia, New Guinea, Samoa, Micronesia, and
Fiji [17]. The species plays important roles in the envi-
ronment (ornamental), as a human food source and in
folklore medicine. The roots are known to contain a
number of potent molluscicidal steroidal saponins [18],
while the bitter principle taccalin (1), along with an ester
and alcohols have also been isolated from the plant [19].
From the leaves of the plant harvested from Southern
Sudan, Abdel-Aziz et al. successfully isolated the B-ring
contracted spirotane, leontogenin (2) for the very first time
[20]. This plant is also known to contain the microtubule
stabilizers; taccalonolides A, B, E and N (3–6), which have
clinical potential for the treatment of cancer [21]. Jagtap
and Satpute have recently identified flavonoids (like dios-
min, rutin, epigenin, hesperidin, quercetin and isoquercetin
by HPTLC) from the tubers of this plant and have attrib-
uted the presence of these flavonoids to the food value of
the plant tubers [22]. While the presence of the cytotoxic
components (3–6) could explain the poisonous nature of
the tubers of this plant, additional uses in folklore medicine
are described in the database of plants from Micronesia
[23].




































The Tamaricaceae (the tamarisk family) are mostly
composed of phenolics and gall polyphenolics (flavonoids,
tannins, phenolic aldehydes), terpenoids, ellagic acid
derivatives and ferulic acid derivatives. The most investi-
gated species of the Tamaricaceae from North Africa are of
the Tamarix genus (T. aphylla and T. nilotica) [24–40].
Several metabolites have been isolated from T. aphylla,
including the unique diaryloxy furanofuran lignan, (?)-
2e,6e-bis-(1-oxy-2,3-dimethoxyphenyl)-3,7-dioxabicyclo-
[3,3,0]octane (7), the polyphenolic l0-decarboxydehy-
drodigallic acid (8) and the glyceryl ester, 1-isoferulyl-3-
pentacosanoyl glycerol (9) from the stem bark [24]. From
the stem bark of the same Egyptian species, Merfort et al.
further isolated the triterpenes; isomyricadiol (10), its 3b
isomer myricadiol (11), along with its 3-ketone (12) [25].
From the leaves, Saleh et al. identified the sulphunated
flavonoid, rhamnetin glucuronide trisulphate [26], while
Orabi et al. recently isolated the cytotoxic tannins,
including three new ellagitannin monomers, nilotinins M5–
M7 (13–15), a dimer, nilotinin D10 (16), and a trimer,
nilotinin T1 (17), together with three known dimers, hir-
tellin D (18) and tamarixinins B (19) and C (20), and a
trimer, hirtellin T2 (21) as the major constituents of the
MeOH and acetone extracts [27]. From the galls of this
plant, Orabi et al. had also previously isolated an ellagi-
tannin, phyllagallin M1 (22), a gallo-ellagitannin, phylla-
gallin D1 (23), and four gallotannins, phyllagallin M2 (24)
and phyllagallins D2–D4 (25–27), in addition to known
ellagitannins and three phenolics of lower molecular
weight, structurally related to hydrolyzable tannins [i.e.
3,30-di-O-methylellagic acid-40-O-b-D-glucopyranoside
(28), dehydrotrigallic acid (29), and flavogallonic acid
dilactone (30)] [28]. Meanwhile, Nawwar et al. had
isolated the galloyl glucoses; 2,6-digalloyl glucose and 3,6-
digalloyl glucose [29], and the novel natural polyphenol,
2-O-galloyl-3-O-(3,4,5,6,7-pentahydroxybiphenyl ether-8a-
carboxylic acid-1-carboxyloyl)-4,6-(S)-hexahydroxybiphe-
noyl-(a/b)-4C1-glucopyranose, commonly named tamar-
ixellagic acid (31), together with the known
dehydrodigallic and dehydrotrigallic acids (32 and 33)
[30]. El Ansari et al. had also isolated the sulphunated and
acylated flavonols; kaempferol-7,40-dimethyl-ether-3-sul-
phate and quercetin 3-O-isoferulyl-b-glucuronide from the
flowers of this plant [31]. Traditionally, this plant has been
used as a shade tree in horticulture and locally as a fire
barrier, since the high salt content of its leaves makes it
difficult to burn [32]. The tested biological activities of the
isolates rather show that compounds 17, 19 and 20 have
significant human tumour-selective cytotoxicities which
were higher than those of synthetic and natural potent
cytotoxic compounds, including polyphenols, and compa-
rable with those of 5-fluorouracil and melphalan [27].
The investigation of the sister species T. nilotica yielded
several metabolites including, from the flowers, the digal-
loylglucose nilocitin (34), which was the first example of a
galloyl glucose not substituted at the anomeric position
[33], along with phenolic lactone 3,4,8,9,10-pentahydroxy-
dibenzo[b,d]pyran-6-one (35) and ellagic acid (36) [34].
Nawwar et al. also isolated flavonoids from the flowers of
this species, viz, the ethyl ester of kaempferol 3-O-b-D-
glucuronide, the methyl and ethyl esters of quercetin 3-O-
b-D-glucuronide, together with kaempferol 3-O-sulphate-
7,40-dimethyl ether and the free aglycones from the aque-
ous extract [35]. From the leaf extracts Abouzid et al.
isolated methyl ferulate 3-O-sulphate (37) for the first time
from a natural source, together with coniferyl alcohol 4-O-
sulphate (38), kaempferol 40-methyl ether (39), tamarixetin
(40) and quercetin 3-O-b-D-glucupyranuronide (41) from
the n-butanol soluble fraction of the extract and pentacyclic
triterpenoid, 3a-(300,400-dihydroxy-trans-cinnamoyloxy)-D-
friedoolean-14-en-28-oic acid (42) from the n-hexane sol-
uble fraction of the extract [36]. Hydrolyzable tannins were
also isolated by Orabi et al. from the aqueous acetone
extract of T. nilotica leaves, particularly three new helli-
noyl-type ellagitannins; nilotinins M4 (43), D7 (44), and
D8 (45), and a new macrocyclic-type, nilotinin D9 (46),
along with eight known tannins, hirtellins C (47), and F
(48), isohirtellin C (49), tellimagrandins I and II, and 1,2,6-
tri-O-galloyl-b-D-glucose (50), hirtellin B (51) and tamar-
ixinin A (52) [37], as well as the novel ellagitannin
monomer, nilotinin M1 (53), and three dimers, nilotinins
D1 (54), D2 (55) and D3 (56), together with six known
tannins, the dimer hirtellin A (57), remurins A (58), and B
(59), 1,3-di-O-galloyl-4,6-O-(S)-hexahydroxydiphenoyl b-
D-glucose (60), gemin D (61) and hippomanin A (62), the
last two being both monomers which were isolated for the
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first time from this plant species [38]. From the roots of the
plant, Barakat et al. isolated the novel glyceride, niloticol,
the novel aldehyde, isoferulaldehyde (63), together with
the known aldehyde, ferulaldehyde (64) [39]. Meanwhile,
Nawwar et al. had earlier reported the isolation of the
furanofuran lignan (±)-syringaresinol (65), reported for the
first time from the Tamaricaceae, together with the new
natural product ellagic acid 3,30-dimethyl ether 4-O-b-D-
glucopyranoside (66), in addition to the known con-
stituents; isoferulic acid (67), gallic acid (68), dehydrodi-
gallic acid (69) and an ellagic acid derivative (70) [40]. An
examination of the aerial parts of the species harvested in
Saudi Arabia rather yielded several polyphenolic con-
stituents, including the new pentacyclic triterpenoid, 3-O-
trans-caffeoylisomyrica-diol (71), in addition to ten known
compounds viz N-trans-feruloyltyramine (72), b-sitosterol
(73), clematine (74), isoferulic acid methyl ester (75),
ellagic acid (76), its 3-methyl ether (77), naringenin (78),
kaempferol-7,40-dimethyl ether (rhamnocitrin-40-methyl
ether) (79), kaempferide (80) and dilleneti (81) [41].
Table 1 Summary of ethnobotanical uses versus measured biological activities of isolated secondary metabolites from Taccaceae and
Tamaricaceae
Plant family Plant name
(country)












Diverse uses, including; the tuber
serves as an important food and the
starch is used to stiffen fabrics. The
bitter raw tubers are generally used
to treat stomach ailments (mainly
diarrhea and dysentery)










Shade tree and fire barrier Stem
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Used in the Egyptian traditional
medicine as an antiseptic agent. The
plant has been used to expel fever,
relieve headache, to draw out
inflammation, and as an
aphrodisiac. The flowers have
demonstrated hepatoprotective and
antioxidant activities
























The plant decoction is used externally

































































































































































































































































































































































































































































































































































































































































































































































































































































39: R1 = H, R2 = OCH3, R3 = OH
40: R1 = OH, R2 =OCH3, R3 = OH











































































































































































































































































































































































































































































































































































































































































































































































































































































76: R1 = H











79 CH3 H CH3
80 H H CH3
























































































88 R1 = OC.CH:CH.C6H5, R2 = R3 = H
89 R1 = OC.CH:CH(CH2)13.Me, R2 = R3 = H
90 R1 = OC.C6H5, R2 = R3 = H
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The biological activities of the tested isolated principles
shows that compounds 39, 40 and 42 exhibited 1,1-
diphenyl-2-picrylhydrazyl radical scavenging activity with
IC50 values of 35.2, 37.0 and 21.2 lM, respectively [36].
Meanwhile, the hydrolyzable tannins from the leaves
showed cytotoxic activity against four human tumor cell
lines at the lower micromolar range; compounds 45 and 57
showing the highest cytotoxic effects, with compound 45
exhibiting CC50 values of 22.9 and 32.3 lM against
promyelocytic leukemia (HL-60) and human squamous
carcinoma (HSC-2) cell lines respectively, while com-
pound 57 showed respective values of 18.4 and 31.3 lM
[37]. Of the compounds isolated from the Saudi species,
compound 71 demonstrated better antioxidant activity
(IC50 value of 3.56 lM) than the reference compound
quecertin (5.72 lM) [41], apart from the multiple known
biological activities of the other isolates like b-sitosterol
(e.g. antioxidant [42], anticancer [43], analgesic [44] and
anti-inflammatory [44, 45]), ellagic acid (e.g. anti-prolif-
erative [46], antioxidant and anticancer [47, 48]), just to
mention these two compounds.
Nawwar et al. have also recently isolated twenty phe-
nolic compounds from the aerial parts of Reaumuria ver-
miculata (Tamaricaceae) [49], a plant whose decoction is
used externally or taken internally to cure fromitch and
bruises [50]. The isolates included four metabolites which
had not been reported previously to occur as natural
products, namely; tamarixetin 3,7-disulphate (82),
3-methoxyellagic acid 4,40-disulphate (83), 2-O-dehy-
drodigallic acid monocarboxyloyl-3-O-galloyl-(a/b)-glu-
cose (84) and the ellagitannin dimer, vermaculitin (85) [49,
50], meanwhile kaempferol-3,7-disulphate (86) is known to
have been isolated for the first time from the Northern
African species [51]. Compounds 84 and 85 were shown to
be cytotoxic ellagitannins, which demonstrated radical
scavenging capacity using both the DPPH method and the
ORAC assay. Additionally, both compounds were cyto-
toxic against prostate cancer cell lines (PC-3), with IC50
values of 1.5 and 0.45 lM respectively [49, 50]. Plants of
the Tamaricaceae, particularly T. nilotica, have been
investigated for their anticancer properties [52]. It is also
recorded in ancient Egyptian papyri that this plant was used
to expel fever, relieve headache, draw out inflammation
and as an aphrodisiac, in addition to its use in Egyptian
traditional medicine as an antiseptic agent [53]. In Egypt,
different parts of Tamarix are used in traditional medicine.
For example, the leaves and young branches are cooked for
oedema of spleen and mixed with ginger for uterine
infections, while the bark, when boiled in water with
vinegar is used as lotion against lice [54]. The above uses
clearly correlate with some of the aforementioned biolog-
ical activities of the isolates.
3 Thymelaeaceae and Tribulaceae
The Thymelaeaceae are known for the presence of daph-
nane diterpenes, coumarins and a broad range of other
compounds, including lignans and phenolics. A summary
of the medicinal uses and biological activities of the
compounds of the Northern African Thymelaeaceae and
Tribulaceae are shown in Table 2. From the Thymelaea-
ceae, the most investigated species from Northern Africa
are those of the genus Thymelaea (T. hirsuta and T.
lythroides, the latter being more common in Morocco,
while the former is the only species known in Egypt). The
coumarin daphnoretin (87) was isolated from the leaves
[55] and roots [56] of T. hirsuta, the 12-hydroxy-daphnane
esters; gnidicin (88), gniditrin (89) and genkwadaphnin
(90), the aliphatic C-12 ester, 12-O-heptadecenoyl-5-hy-
droxy-6,7-epoxy-resiniferonol-9,13,14-orthobenzoate (91)
and the novel aliphatic C-12 ester 12-O-butenyl-5-hy-
droxy-6,7-epoxy-resiniferonol-9,13-14-orthobenzoate (92)
were isolated from the leaves and twigs [57] while the
daphnane diterpenoids; hirseins A (93) and B (94) were
isolated from the aerial parts [58], and the flavonoid
vicenin-2 (95) was isolated from the leaves [51].
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From the aerial parts of T. lythroides, Kabbaj et al.
successfully isolated eight secondary metabolites, includ-
ing the depsipeptide bassiatin (96); the coumarins daphe-
none (97) and daphnelone (98), the dicoumarin daphnoretin
(99), the lignans; d-sesamin (100) and wikstromol (101),
the flavonoid glucoside trans-tiliroside (102), and the
dicoumarin rutarensin (103) [59]. Although the isolated
compounds were not tested by the authors of the afore-
mentioned paper, it was suggested that d-sesamin (100),
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considered as important chemotaxonomic markers of the
species [59], a claim which is still under investigation.
Among the isolated compounds, daphnoretin (87) is
known to be a cancer chemopreventive agent by inhibiting
tyrosine-specific protein kinase, with insignificant cyto-
toxicity against human cell lines [56], while the hirseins
(93 and 94) were shown to be inhibitors of melanogenesis
in B16 murine melanoma cells [58]. Some of the 12-hy-
droxy-daphnane esters are known to activate protein kinase
C (the tumour-promoting receptor site) [60] and are further
claimed to possess anti-tumour activities in vivo against
P-388 leukemia in mice [61, 62]. Furthermore, the mech-
anism of antiproliferative activity of daphnoretin has been
recently explored, showing that the compound causes death
of human osteosarcoma (HOS) by blocking cells succes-
sively in G2/M phases and activating the caspase-3 path-
way [63]. It has recently been shown that this compound
displays antiviral activity [64], induces respiratory burst in
rat neutrophils through protein kinase C activation [65, 66]
and is a well known antineoplastic agent (inhibits or pre-
vents the proliferation of neoplasms) [67].
Plants from the genus Thymelaea are known to be used
to treat a wide range of diseases, including; prostate
inflammation, diabetes, rheumatism, otitis and cancer of
the uterus (particularly T. lythroides) [68]. This has been
confirmed by a recent ethnopharmacological survey of
traditional plants used for cancer treatment in Morocco
[69]. In Tunisia, T. hirsuta is used traditionally as an
antiseptic and anti-inflammatory agent and for the treat-
ment of hypertension by external application [58]. The
anticancer properties of the aforementioned compounds
could justify the use of Thymelaea species for the treatment
of uterine cancer, prostate inflammation and other related
infirmities.
Meanwhile, the Tribulaceae are known for steroids
(steroidal saponins and steroidal glycosides). From the
Northern African Tribulaceae, the remarkable species
investigated are of the genus Tribulus (T. pentandrus, T.
terrestris, T. megistopterus subsp. pterocarpus and T.
parvispinus), harvested in Egypt [70–73]. Traditionally, T.
terrestris is known for diverse uses [74], including the
ability to increase appetite, increase sexual desire in
humans, regulate heart rate, blood pressure and cholesterol
levels, treatment of prostatic hyperplasia, reducing the
symptoms and prostate volume, etc. [75], while the organic
and aqueous extracts from the fruits, leaves and roots have
shown antimicrobial properties [76]. The plant is also
claimed to possess anticancer [77], anticholinergic [78],
Table 2 Summary of ethnobotanical uses versus measured biological activities of isolated secondary metabolites from Thymelaeaceae and
Tribulaceae
Plant family Plant name
(country)










Used traditionally as an antiseptic and
anti-inflammatory agent and for the
treatment of hypertension by external
application [58]. Generally, Thymelaea
species are used for the treatment of
uterine cancer, prostate
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Plants from this genus have diverse uses,
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appetite, increase sexual desire in
humans, regulate heart rate, blood
pressure and cholesterol levels,
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antifilarial [79], anti-malarial [80], CNS depressant and
stimulant [81], hypoglycemic effect [82], immunologic
effect [83], smooth muscle relaxant and stimulant activity
[84] and other important activities [85]. Kostova and
Dinchev have previously published a review on the
chemical diversity of saponins isolated from this species
[86]. From the Northern African species from this genus,
Saleh et al. detected twenty five flavonoid glycosides from
extracts of T. pentandrus and T. terrestris, belonging to the
common flavonols; kaempferol, quercetin and isorham-
netin, together with the 3-gentiobiosides as the major
compounds [70]. The authors also found traces of a flavone
(tricin) glycoside in T. pentandrus. The above study per-
mitted the authors to separate the Tribulaceae as a distinct
family from Zygophyllaceae [70]. Furthermore, Hamid
et al. observed that native steroidal glycosides of both T.
pentandrus and T. megistopterus subsp. pterocarpus were
very similar to each other, but that steroidal glycosides
from T. parvispinus was remarkably different [71]. The
authors elucidated the 10 chemical structures (104–113) of
the related aglycones that have been reported from the
genus Tribulus [71], meanwhile Mahalel isolated the ster-
oidal glycoside pentandroside A (114) from the aerial parts
of T. pentandrus and evaluated its antimicrobial activity
[72]. Pentandroside A exhibited strong activities against B.
cereus, S. aureus, S. marcescens, E. coli, and P. putida,
while also exhibiting strong susceptibility against E. coli at
all tested concentrations, the largest clearing zone being at
100 lg/disc (14 mm). The results further showed that
pentandroside A was more effective than ampicillin,
cephaloridine and pencillin G and similar to cortimoxazole
at concentration 25 lg/disc (11 mm of diameter). Com-
pound 114 had been previously isolated from the same
plant species, along with the related analogues; pentan-
drosides B-G (115–120), although the isolated compounds
were not previously tested [73]. Furthermore, the flavonoid
glycosides; quercetin 3-O-glycoside (121), rutin or quer-
cetin 3-O-rutinoside (122) and kaempferol 3-O-glycoside
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4 Ulvaceae, Umbelliferae and Urticaceae
Ulvaceae contain polyunsaturated fatty acids with algicidal
activities, phenolic compounds with antioxidant activities,
sterols, terpenss and polyphenolic compounds [88–90]. A
summary of the medicinal uses and biological activities of
the compounds of the above plant families are indicated in
Table 3. Marine algae (Ulvaceae) are known for their wide
variety of uses as food, in industry and in medicine [91].
Additionally, their bioactive components have a broad
range of pharmacological functions [88–95]. Ulva lactuca
(commonly known as sea lettuce), for example can be used
in salads and soups, ice cream, other food products, and
medicine [96]. The species is also used to monitor envi-
ronmental pollution, since the plant thrives in moderate
levels of nutrient pollution [96]. Awad isolated the steroid
3-O-b-D-glucopyranosyl-stigmasta-5,25-dien (124), which
exhibited topical anti-inflammatory activity in the mouse
ear oedema assay [95]. Compound 124 as well showed
antimicrobial activity against a broad range of Gram-pos-
itive and Gram-negative bacteria, fungi and yeast strains
[95]. This proves that the consumption of the plant as food
may be of both dietary and medicinal importance. El Ashry
et al. also carried out phytochemical investigations of
the same species, leading to the isolation of two new
compounds; (E)-6-heptacosen-5-one (125) and (E)-6-
Table 3 Summary of ethnobotanical uses versus measured biological activities of isolated secondary metabolites from Ulvaceae, Umbelliferae
and Urticaceae
Plant family Plant name
(country)








Used in salads and soups, ice cream, other food products, in
medicine and to monitor environmental pollution [96]
Whole plant 124–130 124 exhibited anti-
inflammatory activity







Plants of the genus Daucus are used as diuretics, emollient,
vermifuge, carminative and against stomach ache [93,
94], while Daucus carota has edible roots [100]
Leaves and
stems




















Used traditionally for the treatment of skin disorders such as
psoriasis and vitiligo [100–102]. Also used to treat
irregular menstruation, as a diuretic, and for the treatment
of leprosy, kidney stones and urinary tract infections [108]





Aerial parts 73, 159–
161









The plant intoxicates grazing animals, although the plant has
several uses in Moroccan traditional medicine [131]
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octadecen-5-ol (126), along with four known compounds;
(Z)-10-hexacosene (127), docosanoic acid (128), palmitic
acid (129), and isofucosterol (130), (Z)-10-hexacosene
and docosanoic acid being isolated for the first time from
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The Umbelliferae (apiaceous plants) are known for the
presence of saponins, sesquiterpene lactones, coumarins,
flavone glucosides, tanins and a broad range of volatiles.
The family has been previously discussed in this review
series under the Apiaceae [14], but we further highlight
herein some species that were not included in the previous
review and provide a more in-depth discussion of this
family. Plants of the genus Daucus have been used by
natives of some Northern African countries as diuretics,
emollient, vermifuge, carminative and against stomach
ache [98, 99], some of the species having edible roots, e.g.
Daucus carota [100]. Salam et al. identified six new
sesquiterpene lactone esters; daucoguaianolactones A–F
(131–136), and one new sesquiterpene lactone; dau-
coeudesmanolactone A (137) from the leaves and stems of
Daucus glaber [101], along with the known sesquiterpene
lactones talasins A and B and badkhysin. Bioactivity
assessment showed that compounds 134, 137, and talasins
A and B showed moderate cytotoxicity against P-388
leukemia cells [101]. From the leaves and stems of the
same species, Sallam et al. also isolated three new
phenylpropanoid triesters, glaberins A–C (138–140),
compounds 138 and 139 showing cytotoxicity against
P-388 murine lymphocytic leukemia cells with respective
IC50 values of 55 and 44 lg/mL [102]. Ahmed et al. rather
isolated rare trisubstituted sesquiterpenes daucanes (141–
144) from the sister species D. carota, collected from the
wild [103]. The isolated compounds also included the
polyacetylene falcarindiol (145) and the sesquiterpene
coumarin ferulenol (146). The assessment of the antimi-
crobial activities of these compounds showed that the MIC
values for 141 and 142 were\2 mg/mL against Staphy-
lococcus aureus, Streptomyces scabies, Bacillus subtilis,
Bacillus cereus as well as the gram negative species
Pseudomonas aeroginosa. Meanwhile, compound 146 had
an estimated MIC\ 2.5 mg/mL against S. aureus, S.
scabies, B. subtilis, B. cereus and P. aeroginosa and within
the range 5 mg/mL\MIC\ 4.5 mg/mL against E. coli,
F. oxysporum and A. niger. Compounds 144 and 145 had
MIC values \2.5 mg/mL against all the above tested
microorganisms but showed no antibacterial effect against
F. oxysporum and E. coli [103]. These results are in
accordance with the use of wild carrots in traditional
medicine; extract of the plant are used traditionally for the
treatment of hepatic and renal insufficiency as well as for
skin disorders (microbial infections) [104], while the
extracts of the wild plants are also known to exhibit
antioxidative and iron-chelative properties. They could also
be suggested for venereal diseases, skin diseases like sca-
bies and eczema as well as the treatment of stomach ache.
In Northern Africa, plants of the genus Ammi (Umbel-
liferae) are known to be native in Egypt and some of its
species are remarkably important in traditional medicine,
e.g. A. mujus is used traditionally for the treatment of skin
disorders such as psoriasis and vitiligo (acquired leuko-
derma) [105–107]. The plant is also used to treat irregular
menstruation, as a diuretic, and for the treatment of
leprosy, kidney stones and urinary tract infections [108].
Clinical trials of the efficacy of Fructus Ammi Majoris (the
dried ripe fruits of this species) and xanthotoxin for the
treatment of vitiligo, psoriasis, and hypopigmentation tinea
versicolor have proven positive [109–115]. Consequently,
A. mujus is known to be one of the most important
medicinal plants which has been used industrially for the
isolation of its active principles in Egypt [116]. The plant
has also been used in traditional medicine for xanthotoxin
production [116, 117], an important drug for leukodermia
treatment [118, 119]. Phytochemical investigations of the
fruits of this plant by Elgamal et al. led to the identification
of a new coumarin named isoarnottinin (147), together with
two of its glucosides (148–149) [120]. Moreover, seven
known coumarins; scopoletin (150), 8-(200-acetoxy-300-hy-
droxy-300-methylbutoxy)psoralen (151), 8-hydroxy-5-
methoxypsoralene (152), apiumetin (153), dihydroxan-
thyletin (154), lomatin (155) and ammirol (156), as well as
oleanolic acid (157) and mannitol (158) were also isolated
from the dried fruits [120]. The isolated compounds are
known for a wide range of pharmacological activities, e.g.
the glycoside of compound 147 showed high antibacterial
effect against the plant pathogen Erwinia carotovora, with
an MIC value of 100 lg/mL [121]. Moreover, this com-
pound also exhibited significant phytotoxic activity against
lettuce and modest cytotoxic activity against HeLa cell line
with an IC50 value of 0.84 mg/mL [107]. Thus, the authors
of this study concluded that the isolate isoamottinin 40-
glucoside may play a phytoalexin or allelopathic role for
plants and that this compound may be a candidate for an
antibacterial agent or a bioherbicide, beyond its other
known activities [122]. Scopoletin is known to exhibit a
broad range of pharmacological activities, including; anti-
fungal [123], acetycholinesterase inhibition [124], insect
feeding deterrent and growth inhibitory activities [125] and
aldose reductase inhibitory activity [126], while the cou-
marin and its derivatives have also shown antitumour
actvities [127, 128]. Additionally, Selim and Ouf recently
isolated the coumarins 6-hydroxy-7-methoxy-4-methyl
coumarin (159), 6-hydroxy-7-methoxy coumarin (160) and
xanthotoxin (161), together with b-sitosterol (73) from the
aerial parts of the plant [129]. Meanwhile, Bencheraiet
et al. isolated the flovonoids; quercetin (162) rhamnetin
(163), isorhamnetin (164), rhamnazin (165), three 3-O-
glucosides respectively linked to; rhamnetin (166),
isorhamnetin (167) and rhamnazin (168); one 7-O-glu-
coside of isorhamnetin (169), two diglycosides; 3-O-rutin
of quercetin (170) and isorhamnetin (171), together with
quercetin 7,3,30-O-triglucoside (172) from the sister
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species, A. visnaga, collected from Algeria (used in
Algerian folk medicine to treat vitiligo) [130]. The bio-
logical tests showed that compounds 159 and 160 are good
anti-inflammatory agents, both compounds exhibiting
appreciable inhibition of edema, particularly compound
159, which exhibited an 87 % edema inhibition of
37.81 %, comparable with that of the standard drug indo-
methacin (60.50 % at 0.01 mg/100 g dose), while com-
pound 161 exhibited mild anti-inflammatory activity [129].
On the contrary, all coumarins from A. mujus (159–161)
were found to have no reliable antiviral activity against
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Ferula communis (Umbelliferae) is a perennial weed
found in several Mediterranean countries, the leaves of
which are known amongst Arab cattle rearers to intoxicate
animals, although the plant has several uses in Moroccan
traditional medicine [131]. Lamnaouer et al. have identified
the toxic products of this plant to be two isoprenylated
4-hydroxycoumarins; ferulenol (173) and x-hydroxyferu-
lenol (174, isolated from this plant for the first time), both
natural products showing haemorrhagic action [132]. The
roots of the sister species, F. hermonis, are known to be the
source of seventeen antibacterial and antioxidant daucane
sesquiterpenoids (175–191) [133]. This plant has long been
used in the Middle East as an aphrodisiac, and for the
treatment of frigidity and impotence [134, 135]. The iso-
lated compounds exhibited DPPH radical scavenging
activities, with IC50 values varying from 11.5 to 183.5 lM,
with teferidin (189), ferutinin (190) and teferin (191)
notably exhibiting the highest radical scavenging activities,
comparable with that of the standard drug Ascorbic acid
(IC50 = 12.5 lM). Geroushi et al. had previously isolated
the anti-inflammatory sesquiterpenes (189–191) from the
root oil of F. hermonis [136]. The antimicrobial activity of
the isolated metabolites (189–191) was also evaluated by
determination of MIC using the broth microdilution
method against six bacterial strains and one fungal strain
(Pseudomonas aeruginosa PAO1, Escherichia coli, Bacil-
lus subtilis ATCC6633, Mycobacterium bovis BCG Pas-
teur, Mycobacterium tuberculosis H37Rv, Staphylococcus
aureus ATCC6538 and Candida albicans SC5314). Again,
compounds 189, 190 and 191 demonstrated potent activity
against the Gram ?ve (S. aureus, B. subtilis), as well as the
Mycobacterium strains M. bovis BCG and M. tuberculosis
H37Rv. None of the isolated compounds exhibited a sig-
nificant antifungal activity [133–135]. The roots of the
sister Tunisian species F. lutea have rather been charac-
terized by antioxidant, anti-acetylcholinesterase and cyto-
toxic dihydrofuranocoumarins; (-)-5-hydroxyprantschimgin
(192) and (-)-5-hydroxydeltoin (193) [137]. These com-
pounds were isolated along with eight known compounds;
(-)-prantschimgin (194), (-)-deltoin (195), psoralen
(196), xanthotoxin (197), umbelliferone (198), caffeic acid
(199), b-sitosterol (73) and stigmasterol. Meanwhile the
aerial parts of the Algerian species, F. vesceritensis, tra-
ditionally used for the treatment of neurological disorders
(tranquillizer, antihysteric), dysentery, digestive disorders,
rheumatism, headache, arthritis and dizziness [138], has
been characterized by the presence of sesquiterpenes and
sesquiterpene coumarins [139]. Oughlissi-Dehak et al.
analysed the chemical composition of the dichloromethane
extract of aerial parts of the plant and found them to be
composed of five new sesquiterpenes (200–204), together
with six related compounds (205–210) identified, respec-
tively as; feselol (205), farnesiferol A (206), 2-acetyl-
jaechkeanadiol-6-anisate (207), lasidiol-10-anisate (208),
10-oxojaesckeanadiol-6-anisate (209) and lapidol (210)
[139]. Moreover, ferulsinaic acid (211) is a sesquiterpene
coumarin with a rare carbon skeleton, known to be the
taxonomic marker of the genus Ferula [140].
Plants of the genus Carum (Umbelliferae) have a wide
range of industrial and pharmacological uses, e.g. C. carvi
(also known as Caraway) has been used in Europe for
flavouring bread, sauerkraut, candies, meat products, sau-
ces, cheese and alcoholic liqueurs [141, 142]. Moreover,
the seeds of this plant have been used traditionally for the
treatment of colic, appetite loss, anti-malarial preparations,
as a vermifuge and for digestive disorders, etc. [142].
Laouer et al. have investigated the essential oil of the aerial
parts (leaves and flowers) of the sister species, C. mon-
tanum (a plant commonly grazed by livestock), harvested
from the Megress Mountain in Algeria, although no
medicinal applications are known for the Algerian species
locally [142]. This study led to the isolation of phenyl-
propanoids with antimicrobial properties [142]. These
include; nothoapiole (212), myristicin (213), apiole (214)
and dillapiole (215) [142]. Meanwhile, Benahmed et al.
had previously isolated the new furanocoumarin glucoside,
xanthotoxin-5-O-b-D-glucoside named carumoside (216),
together with the known coumarin xanthotoxin (217), from
aerial parts of the Algerian species, but did not test the
isolated compounds [143]. It should be noted that although
coumarins are common in apiaceous plants (particularly
within the genera Apium, Ammi andMagydaris) [144–148],
the presence of the coumarin xanthotoxin (217) in both
species (C. carvi [146] and C. montanum [143]) and the
concurrent absence of its 5-glucosides in C. carvi may be
an indication that the biosynthesis of 5-glucosides of
furanocoumarins is a distinctive characteristic of the
Algerian species, C. montanum [143].
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Smyrnium olusatrum (Umbelliferae) is a well known
medicinal plant, which is locally cultivated in Libya where
the young shoots are used as pot herb and edible salad in
some areas of the country [149]. The plant is also reported
to be used as an antiscorbutic in Palestine [150]. El-Gamal
examined the fruits of this plant and isolated three
sesquiterpene lactones, namely; 1b,8b-dihydroxy eudes-
man 3,7(11)-dien 8a,12 olide (218), 1b,8b-dihydroxy
eudesman 4(15),7(11)-dien 8a,l2 olide (219) and
1b,10a;4a,5b-diepoxy 6-b-hydroxy-glechoman-8a,12
olide (220), together with four related known sesquiterpe-
nes (221–224) [149]. Although previous in vitro cytotoxi-
city assays had showed that the CH2Cl2 extract of the fruits
of the plant exhibited significant cytotoxicity
(IC50 = 9.0 lg/mL) against P-388 mouse lymphoma cells
[151, 152], the study by El-Gamal rather showed that the
isolated compounds (218, 219 and 221–224) only showed
marginal activity, with respective IC50 values of 60, 65, 42,
58, 94 and 88 lg/mL [149].
From the Urticaceae, Urtica dioica (or nettle) is widely
used as a food supplement (with salad) in the East ofMorocco
[153]. The plant is also known in Eastern Moroccan tradi-
tional medicine for its antihypotensive and antidiabetic
properties [154, 155], meanwhile its extracts have displayed
hypoglycemic [153, 156], antioxidant, antimicrobial, antiul-
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antirheumatic [160] and hepatoprotective [161] effects. It has
also been demonstrated that a preparation containing several
medicinal plants, including U. dioica exhibited antidiabetic
activity [162] and could also be used to treat allergic rhinitis
[163]. Bnouhamet al. investigated the hypoglycemic effect of
aqueous extract of U. dioica, harvested from Eastern Mor-
occo, onhyperglycemia inducedbyoral glucose tolerance test
(OGTT) and on alloxan-induced diabetic rats, with the view
of determining one of the probable mechanisms of nettle’s
antihyperglycemic effect [149]. Their results showed that U.
dioica had a significant antihyperglycemic effect which may
be partly as a result of the reduction of intestinal glucose
absorption, thus suggesting that the plant is recommendable
as a food supplement for the management of diabetes.
Scho¨ttner et al. have isolated the following ligans; (?)-
neoolivil (225), (-)-secoisolariciresinol (226), dehydrodi-
coniferyl alcohol (227), isolariciresinol (228), pinoresinol
(229) and 3,4-divanillyltetrahydrofuran (230) from the root
polar extracts of the plant [164, 165]. The compounds were
tested for their affinity to human sex hormone binding glob-
ulin (SHBG) and results showed that all lignans except (-)-
pinoresinol developed a binding affinity to SHBG in the
in vitro assay, with the affinity of (-)-3,4-divanillyltetrahy-
drofuran proving to be significantly high, when compared
with those of the other isolates [164]. These results could
suggest the further examination of these compounds (225–
228 and 230) and plant lignans in general for the development
of drugs against benign prostatic hyperplasia (BPH).
5 Verbenaceae and Vitaceae
Verbenaceae contain triterpenoids, flavonoids, chromo-
moric acid derivatives, quinones, apocarotenoids and lig-
nans [166], while Vitaceae are known to be rich in
flavonoids, terpenes, organic acids, vitamins, carbohydrats,
lipids and enzymes [167]. A summary of the medicinal
uses and biological activities of the compounds of the
plant families above are indicated in Table 4. Flowering
plants of the genus Clerodendrum (formerly Verbenaceae,
now Lamiaceae) are currently classified in the subfamily
Ajugoideae [168, 169]. The species have diverse uses in
folk medicine, e.g. the aqueous leaf extract of C. glan-
dulosum is traditionally used by people of North-East India
to alleviate symptoms of diabetes, obesity and hyperten-
sion, while the plant is used to prepare a staple diet among
the Zomi tribes (North East India) [170]. The leaf juice of
the sister species C. inerme (commonly used as a hedge
plant) is reportedly used as a remedy to bring down fever
[171]. Phytochemical investigation of the leaf extracts of
C. inerme from Giza in Egypt led to the identification of
five novel complex iridoid glycosides; inerminosides A
and B (231 and 232) [172], as well as inerminosides A1, C
and D (233–235) [173], although the compounds were not
tested. Therefore, the validation of the ethnobotanical uses
of Clerodendrum species from Northern Africa is still
under investigation.
Table 4 Summary of ethnobotanical uses versus measured biological activities of isolated secondary metabolites from Verbenaceae and
Vitaceae
Plant family Plant name
(country)
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Verbena officinalis (Verbenaceae) is a herb that has been
used in traditional Austrian medicine (as tea or liqueur) for
the treatment of infections and fever [174]. Vebena, a
common food supplement derived from this plant, is used
for sore throats and respiratory tract diseases such as
asthma and whooping cough, and for heart conditions such
as chest pain (angina) and fluid retention due to heart
failure [175]. An investigation of V. officinalis and the
sister species V. supina collected in Egypt, led to the
identification of several flavonoid glycosides which per-
mitted to chemically distinguish between the two species
[176, 177]. Although the compounds were not tested, the
favonoid profiles of the species indicated that luteolin-7-
neohesperidoside (236) and diosmetin-7-neohesperidoside
(237) are major components in V. officinalis while the
major component of V. supina was tuteolin-7-glucoside
(238). Both species contained luteolin-7-galactoside (239)
and diosmetin-7-galactoside, together with apigenin-7-
glucoside and chrysoeriol-7-galactoside in minor quantities
[176, 177].
Cyphostemma crotalarioides (Vitaceae) is a plant
known in Sudan for its applications in pest management
programs [176, 177]. The roots are also known to be used
in traditional preparations as pain-killers and for stomach
troubles [178]. To confirm the use of the plant to treat
stomach troubles, Ducrot et al. have successfully isolated
two new antifungal oligostilbenes; cyphostemmins A and B
(240 and 241) [176, 177], along with resveratrol (242) and
some of its known natural oligomers; namely partheno-
cissin A (243), e-viniferin (244), gnetin C (245), pallidol
(246), gnetin E (247) and ampelopsin D (248) [179], from
the roots of the plant species collected from Sudan. Com-
pound 242 and it’s analogues exhibited cancer chemopre-
ventive, antifungal and antibacterial activities [179–189].
6 Zingiberaceae and Zygophyllaceae
A summary of the medicinal uses and biological activities
of the compounds of the above plant families are indicated
in Table 5. The Zingiberaceae are plants possessing rhi-
zomes, including species like ginger and cardamom, which
are commonly used as spices [190]. This family is known
for their labdane diterpenoids. The rhizome powder of
Turmeric (Curcuma longa, Zingiberaceae), for example, is
often added to various food preparations to preserve their
freshness and impart a characteristic flavour. In India,
traditional claims hold that Turmeric powder is effective
against biliary disorders, anorexia, coryza, cough, diabetic
wounds, hepatic disorder, rheumatism, and sinusitis [191].
Demerdash et al. have isolated four compounds, namely;
1-dehydrogingerdione (249), ar-turmerone (250), (-)-
Table 5 Summary of ethnobotanical uses versus measured biological activities of isolated secondary metabolites from Zingiberaceae and
Zygophyllaceae
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caryophyllene oxide (251) and a-turmerone (252) from a
commercial powdered sample purchased from a local
market in Mansoura, Egypt [192]. Although the authors did
not report any biological tests, this plant together with the
sister species C. comosa are known to be rich sources of
diarylheptanoids (e.g. Curcumin, 253) [193, 194], which
are known for their antioxidant [195], antiviral [196],
melanogenesis-inhibitory and cytotoxic [197–200], anti-
Leishmanial [201] and anti-Trypanosomal [202] activities,
just to mention these ones.
The Zygophyllaceae are known for their flavonoid
content. The family has been briefly discussed in this
series previously under Balanitaceae, but the report was
focused on the genus Balanites [14], thereby ignoring the
previously investigated genera Tribulus, Fagonia, Zygo-
phylum and Paganum). In the genus Tribulus, the Egyp-
tian species T. parvispinus [203], T. alatus [204], T.
pentandrus [73], and T. terrestrris [205] have been mainly
investigated. With a wide range of uses in folk medicine,
e.g. the fruits of T. alatus are used in Pakistan for the
treatment of urinary disorders and cough [206, 207]; T.
terrestris has been used for the treatment of impotence,
rheumatism, edema, hypertension and kidney stones
[208–210], since the extract of the plant possesses
aphrodisiac properties probably due to androgen increas-
ing properties [211, 212]; the Tribulus species are known
to be rich in furostane- and spirostane-type steroidal
saponins which exhibit a broad range of pharmacological
functions, e.g. cytotoxic [213], antiproliferative [214],
and antimicrobial effects [215]. The most important iso-
lated compounds from the Northern African species
include; furostanol saponins (254–259) from T. parvispi-
nus, exhibiting cytotoxic activities against U937, MCF7,
and HepG2 cells, with compounds 255 and 258, having
IC50 values of 0.5 and 0.1 lM, respectively against U937
cells [203]. The untested steroidal glycosides (260–265)
were isolated from the aerial parts of T. alatus [204],
while seven new steroidal glycosides; pentandrosides A-G
(266–272) were isolated from the aerial parts of T. pen-
tandrus, with 272 being an unusual acyloxypregnane
aglycone probably derived from the degradation of a
furostan skeleton [73]. From the aerial parts of T. ter-
restris, Hammoda et al. isolated two oligosaccharides
(273 and 274) and a stereoisomer of di-p-coumaroylquinic
acid (275), together with five known compounds (276–
280) [205]. The isolates exhibited antioxidant activities,
with compound 276 (4,5-di-p-trans-coumaroylquinic
acid), showing significantly stronger DPPH free radical
scavenging activity than the total ethyl acetate fraction,
while the IC50 values of the geometric isomers 275 and
276 being comparable with that of the reference com-
pound (Ascorbic acid) [205].
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255 R1= H R2= H
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The Fagonia [216–229] and Zygophylum [230–239]
genera have been extensively explored and reviewed.
Therefore a complete discussion is beyond the scope of this
article. Within the genus Paganum the only species
investigated was P. harmala [240–242], a plant whose
seeds are used for cancer treatment [243], and which are
reported to contain between 2 and 6 % biologically active
alkaloids, mainly b-carbolines, e.g. harman (281), harmine
(282), harmaline (283) and harmalol (284) [241, 244–246].
The methanol extract of seeds of the plant harvested in
Morocco significantly reduced the proliferation of three
tumoral cell-lines; UCP-Med and Med-mek carcinoma, and
UCP-Med sarcoma at concentrations of 20–120 lg/mL
during the first 24 h of contact [240]. The alkaloids (281–
284) were derived from the species harvested in Egypt
[241], together with four untested flavonoid glycosides
[242]. The isolated alkaloids also exhibited antimicrobial
activties against a wide range of organisms, including;
Escherichia coli, Proteus vulgaris, Staphyllococcus aureus,
Bacillus subitilis, Asperagillus niger and Candida albicans
[241].
7 Discussion and Conclusions
This review paper is not an attempt to present an exhaus-
tive overview of compounds from Northern African plant
species and their biological activities, the reason being that
such an attempt is not feasible in a journal article. The main
goal of this review series has been to establish a baseline
for further investigations of North African flora. Data on
plant sources, geographical collection sites and chemical
structures of pure compounds have been retrieved from
literature sources (mainly from the major international
journals on natural products and some available PhD the-
ses, spanning the period 1959–2015). From Taccaceae to
Zygophyllaceae, we have discussed 284 metabolites which
have been isolated from 34 plant species belonging to 11
Northern African plant families. From Tables 1 to 5, it
appears as though the correlation between the application
of plant materials (e.g. in traditional medicines) and the
biological activities of the isolated plant metabolites is
relatively weak (with the exception of a few correlations
marked in bold), when compared with our previous reviews
from Central Africa [247, 248], West Africa [249–252],
Southern Africa [253, 254] and the previously discussed
families from the region [14, 15]. One could easily explain
off this weak correlation by the fact that traditional meth-
ods like boiling, the use of total extracts as mixtures, steam
baths, etc. do not match the typical chemical extraction
methods employed in a NP laboratory. The survey however
portrays the importance of traditional medicine in drug
discovery programs. Previous surveys have also
demonstrated that NPs from African flora have shown a
great diversity of chemical classes with a broad range of
biological activities; including[500 compounds with anti-
malarial activties [255, 256], *100 compounds with
potential anti-mycobacterial activities [257], [400 com-
pounds with potential anticancer activities [258, 259] and
*100 compounds with anti-trypanosomal activities [260,
261]. This leaves us with a huge repository for drug dis-
covery. It should be noted that the tested compounds only
represent a small proportion of NPs from the region which
have been isolated. The chemical scaffolds from the
untested NPs still remain to be explored. From this data
and the previously presented reviews, we are currently
building a searchable database for compounds isolated
from Northern African flora, in order to assist in drug
discovery programs on the continent of Africa.
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